Europe Cell Line Development Market 2027 By Type, By Product, Application, and Geography | The Insight Partners

Europe Cell Line Development Market to 2027 - Regional Analysis and Forecasts by Type (Primary Cell Line, Hybridomas, Continuous Cell Lines, and Recombinant Cell Line); By Product (Equipment and Media & Reagent); Application (Drug Discovery, Bioproduction and Tissue Engineering); and Geography

Publication Month: Feb 2020 | Report Code: TIPRE00009032 | No. of Pages: 160 | Category: Biotechnology | Status: Published
Covid

Cell Line Development market in Europe is expected to grow from US$ 1,207.15 Mn in 2019 to US$ 3,170.94 Mn by the year 2027. This represents a CAGR of 12.8% from the year 2019 to 2027.

The growth of the Cell Line Development market is driven by the factors such as government and private funding for biotechnology research, the launch of innovative technologies for cell line synthesis, and an increase in various research for novel technology-based applications are likely to be the major factors driving the growth of this market in the European region. Europe holds a robust technological base in terms of number of patent filings.

The medical biotechnology has undergone revolutions as a result of various development programs, business strategies that helps to produce, discover, or alter various biomolecules and organisms through bioengineering approaches. Europe holds a robust technological base in terms of number of patent filings. This adds up significantly to the high degree of intellectual property rights in the region leading to its strong position in the cell line development market. Also, efforts taken by the National Government to encourage innovation through incentives provision and tax exemption for R&D and new biotech start-ups are expected to favor the growth of the European cell line development market over the forecast years.

Germany is anticipated to lead the adoptions of cell line development across the European region through the forecast period. Germany is considered to be the biggest hub for biotechnology in Europe and worldwide owing to the presence of large biotech players, high-tech research labs, and massive funding for conduction of research and development. The country headquarters more cell line development companies than any other country in Europe. It is also among the toppers of the international list for the number of studies in the pipeline. The cutting edge and high-quality research present in the country create a lucrative opportunity and presence of an established market for gene synthesis. Therefore, owing to the factors mentioned above, the market for cell line development is expected to grow in the forecast period.

UK Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)

UK Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)

Get more information on this report :



EUROPE CELL LINE DEVELOPMENT – MARKET SEGMENTATION

Europe Cell Line Development Market - By Type

  • Recombinant Cell Line
  • Hybridomas
  • Primary Cell Line
  • Continuous Cell Lines


Europe Cell Line Development Market - By Product

  • Media and Reagent
  • Equipment


Europe Cell Line Development Market - By Application

  • Bioproduction
  • Drug Discovery
  • Tissue Engineering

Europe Cell Line Development Market - By Country

  • UK
  • Germany
  • France
  • Italy
  • Spain

 

Companies Mentioned

  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Sartorius AG
  • SELEXIS
  • BioFactura, Inc.
  • WuXi AppTec
  • LakePharma, Inc.
  • General Electric Company
  • Lonza
  • Corning Incorporated

 

1.           Introduction

1.1         Scope Of The Study

1.2         The Insight Partners Research Report Guidance

2.           Europe Cell Line Development Market – Key Takeaways

3.           Europe Cell Line Development Market – Market Landscape

3.1         Overview

3.2         Market Segmentation

3.2.1        Europe Cell Line Development Market – By Type

3.2.2        Europe Cell Line Development Market – By Product

3.2.3        Europe Cell Line Development Market – By Application

3.2.4        Europe Cell Line Development Market – By Country

3.3         PEST Analysis

3.3.1        Europe – PEST Analysis

4.           Europe Cell Line Development Market- Key Market Dynamics

4.1         Key Market Drivers

4.1.1        Increasing Regenerative Medicine Development Activities

4.1.2        Rising Incidence of Chronic Diseases

4.2         Key Market Restraints

4.2.1        Risk Associated with Cell Line Contamination

4.3         Key Market Opportunities

4.3.1        The rise in production of biosimilars

4.4         Future Trends

4.4.1        Consistent Research in Drug Discovery Activities

4.5         Impact Analysis

5.           Cell Line Development Market – Europe Analysis

5.1         Europe Cell Line Development Market Revenue Forecasts And Analysis

5.2         Market Positioning

5.3         Performance of Key Players

5.3.1        Merck KGaA

5.3.2        Thermo Fisher Scientific Inc.

5.4         Expert Opinions

6.           Europe Cell Line Development Market Analysis –  By Type

6.1         Overview

6.2         Europe Cell Line Development Market, By Type, 2018 & 2027 (%)

6.3         Europe Cell Line Development Market Revenue And Forecasts To 2027, By Type (US$ Mn)

6.4         Recombinant Cell Line Market

6.4.1        Overview

6.4.2        Europe Recombinant Cell Line Market Revenue And Forecasts To 2027(US$ Mn)

6.5         Hybridomas

6.5.1        Overview

6.5.2        Europe Hybridoma Market Revenue And Forecasts To 2027 (US$ Mn)

6.6         Primary Cell Line

6.6.1        Overview

6.6.2        Europe Primary Cell Line Market Revenue and Forecasts to 2027 (US$ Mn)

6.7         Continuous Cell Lines

6.7.1        Overview

6.7.2        Europe Continuous Cell Lines Market Revenue and Forecasts to 2027 (US$ Mn)

7.           Europe Cell Line Development Market Analysis – By Product

7.1         Overview

7.2         Europe Cell Line Development Market, By Product, 2018 & 2027 (%)

7.3         Europe Cell Line Development Market Revenue And Forecasts To 2027, By Product (US$ Mn)

7.4         Media And Reagent Market

7.4.1        Overview

7.4.2        Europe Media and Reagent Market Revenue And Forecasts To 2027(US$ Mn)

7.5         Equipment

7.5.1        Overview

7.5.2        Europe Equipment Market Revenue And Forecasts To 2027 (US$ Mn)

8.           Europe Cell Line Development Market Analysis –  By Application

8.1         Overview

8.2         Europe Cell Line Development Market, By Application, 2018 & 2027 (%)

8.3         Europe Cell Line Development Market Revenue And Forecasts To 2027, By Application (US$ Mn)

8.4         Bioproduction

8.4.1        Overview

8.4.2        Europe Bioproduction Market Revenue And Forecasts To 2027(US$ Mn)

8.5         Drug Discovery

8.5.1        Overview

8.5.2        Europe Drug Discovery Market Revenue And Forecasts To 2027 (US$ Mn)

8.6         Tissue Engineering

8.6.1        Overview

8.6.2        Europe Tissue Engineering Market Revenue And Forecasts To 2027 (US$ Mn)

9.           Europe Cell Line Development Market Revenue And Forecasts To 2027

9.1         Overview

Europe Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

9.2         Europe Cell Line Development Market Revenue And Forecasts To 2027, By Type (US$ Mn)

9.3         Europe Cell Line Development Market Revenue And Forecasts To 2027, By Product (US$ Mn)

9.4         Europe Cell Line Development Market Revenue And Forecasts To 2027, By Application (US$ Mn)

9.5         Europe Cell Line Development Market Revenue And Forecasts To 2027, By Country (%)

9.6         Germany Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

9.6.1        Germany Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)

9.6.2        Germany Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.6.3        Germany Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.6.4        Germany Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.7         UK Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

9.7.1        UK Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)

9.7.2        UK Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.7.3        UK Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.7.4        UK Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.8         France Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

9.8.1        France Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)

9.8.2        France Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.8.3        France Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.8.4        France Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.9         Spain Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

9.9.1        Spain Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)

9.9.2        Spain Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.9.3        Spain Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.9.4        Spain Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.10      Italy Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

9.10.1     Italy Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)

9.10.2     Italy Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.10.3     Italy Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.10.4     Italy Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.        Cell Line Development Market – Industry Landscape

10.1      Overview

10.2      Growth Strategies in The Cell Line Development Market, (%)

10.3      Organic Developments

10.3.1     Overview

10.3.2     Organic Growth Strategies in the Cell Line Development Market, 2016-2019

10.3.3     Expansion

10.3.3.1       Recent Expansion By Players in The Cell Line Development Market

10.3.4     Inorganic Developments

10.3.5     Overview

10.3.6     Inorganic Growth Strategies In The Cell Line Development Market, 2016-2019

10.3.7     Agreements

10.3.7.1       The Cell Line Development Market, By Agreements

10.3.8     Acquisitions

10.3.8.1       Acquisitions By Players in the Cell Line Development Market

Source: The Insight Partners Analysis

11.        Cell Line Development Market – Key Company Profiles

11.1      Merck KGaA

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Financial Overview

11.1.4     Product Portfolio

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Thermo Fisher Scientific, Inc.

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Financial Information

11.2.4     Product /Services Portfolio

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Sartorius AG

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Financial Overview

11.3.4     Product Portfolio

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Selexis

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Financial Overview

11.4.4     Product/Service Portfolio

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Biofactura, Inc.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Financial Overview

11.5.4     Product Portfolio

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      Wuxi AppTec

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Financial Overview

11.6.4     Service Portfolio

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      LakePharma, Inc.

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Financial Overview

11.7.4     Product Portfolio

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8      General Electric

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Financial Overview

11.8.4     Product Portfolio

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9      Lonza

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Financial Information

11.9.4     Product Portfolio

11.9.5     SWOT Analysis

11.9.6     Key Developments

11.10   Corning Incorporated

11.10.1  Key Facts

11.10.2  Business Description

11.10.3  Financial Overview

11.10.4  Product Portfolio

11.10.5  SWOT Analysis

11.10.6  Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary Of Terms

12.3      Methodology

12.3.1     Coverage

12.3.2     Secondary Research

12.3.3     Primary Research

LIST OF TABLES

Table 1.            Europe Cell line development market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 2.            Europe Cell line development market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 3.            Europe Cell line development market Revenue And Forecasts to 2027, By Applicayion (US$ Mn)

Table 4.            Europe Cell line development market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 5.            Europe Cell line development market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 6.            Europe Cell line development market Revenue And Forecasts to 2027, By application (US$ Mn)

Table 7.            Germany Cell line development market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 8.            Germany Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)

Table 9.            China Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)

Table 10.         UK Cell line development market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 11.         UK Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)

Table 12.         UK Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)

Table 13.         France Cell line development market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 14.         France Cell line development market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 15.         France Cell line development market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 16.         Spain Cell line development market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 17.         Spain Cell line development market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 18.         Spain Cell line development market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 19.         Italy Cell line development market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 20.         Italy Cell line development market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 21.         Italy Cell line development market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 22.         Recent Expansion in The Cell Line Development Market

Table 23.         The Cell Line Development Market by Agreements

Table 24.         Acquisitions in the Cell Line Development Market

Table 25.         Glossary of Terms, Cell Line Development Market

LIST OF FIGURES

Figure 1.          Germany Cell Line Development Market, Revenue (US$ Mn), By 2018 & 2027

Figure 2.          Europe Cell Line Development Market By Type Market Share (%), 2018

Figure 3.          Europe Cell Line Development Market By Product Market Share (%), 2018

Figure 4.          Europe Cell Line Development Market By Application Market Share (%), 2018

Figure 5.          Cell Line Development Market Segmentation

Figure 6.          Europe PEST Analysis

Figure 7.          Cell Line Development Market Impact Analysis Of Drivers & Restraints

Figure 8.          Europe Cell Line Development Market – Revenue Forecasts And Analysis – 2018- 2027

Figure 9.          Europe Cell Line Development Market, By Type, 2018 & 2027 (%)

Figure 10.       Europe Recombinant Cell Line Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 11.       Europe Hybridoma Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 12.       Europe Primary Cell Line Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 13.       Europe Continuous Cell Lines Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 14.       Europe Cell Line Development Market, By Product, 2018 & 2027 (%)

Figure 15.       Europe Media And Reagent Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 16.       Europe Equipment Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 17.       Europe Cell Line Development Market, By Application, 2018 & 2027 (%)

Figure 18.       Europe Bioproduction Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19.       Europe Drug Discovery Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 20.       Europe Tissue Engineering Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 21.       Europe Cell Line Development Market Revenue, By Country, 2018 (US$ Mn)

Figure 22.       Europe Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 23.       Europe Cell Line Development Market Revenue And Forecasts To 2027, By Country (%)

Figure 24.       Germany Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 25.       UK Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 26.       France Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 27.       Spain Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 28.       Italy Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 29.       Growth Strategies in The Cell Line Development Market, (%)

Figure 30.       Organic Growth Strategies In The Cell Line Development Market, 2016-2019

Figure 31.       Inorganic Developments In The Cell Line Development Market, 2016-2019

 

The List of Companies - Europe Cell Line Development Market

 

  1. Merck KGaA
  2. Thermo Fisher Scientific, Inc.
  3. Sartorius AG
  4. SELEXIS
  5. BioFactura, Inc.
  6. WuXi AppTec
  7. LakePharma, Inc.
  8. General Electric Company
  9. Lonza
  10. Corning Incorporated

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cell line development market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the Europe cell line development market market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

TIPRE00009032
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing